SIM
HLVX

Sandia Investment Management’s HilleVax HLVX Stock Holding History

Sandia Investment Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,000
Closed -$99.2K – 245
2023
Q1 		$99.2K Hold
6,000
– – 0.02% 174
2022
Q4 		$100K Sell
6,000
-1,900
-24% -$34.3K 0.02% 166
2022
Q3 		$135K Sell
7,900
-4,600
-37% -$66.9K 0.02% 187
2022
Q2 		$137K Buy
+12,500
New +$148K 0.02% 242

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Sandia Investment Management's HLVX Position: Q2 2023 in Review

Sandia Investment Management sold out of HilleVax (HLVX) in Q2 2023, closing a stake of 6,000 shares — an estimated $99.2K sold.

Sandia Investment Management first reported a position in HLVX in Q2 2022 and held it in 4 quarters. The position peaked at $137K in Q2 2022. 54 funds tracked by Wall St. Rank hold HLVX as of Q2 2023.

  • Sandia Investment Management reported no remaining HilleVax position as of Q2 2023 after selling out during the quarter.
  • Sandia Investment Management sold 6,000 HilleVax shares in Q2 2023, an estimated $99.2K.
  • Sandia Investment Management first reported a position in HilleVax in Q2 2022 and held it in 4 quarters.
  • Sandia Investment Management's HilleVax position peaked at $137K in Q2 2022.
  • 54 funds tracked by Wall St. Rank held HilleVax as of Q2 2023.

Based on Sandia Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.